| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 341 |
| 1 | METHOTREXATE SODIUM | 337 |
| 2 | METHOTREXATE | 331 |
| 3 | ADALIMUMAB | 324 |
| 4 | INFLIXIMAB | 320 |
| 5 | GOLIMUMAB | 316 |
| 6 | ABATACEPT | 312 |
| 7 | TOCILIZUMAB | 309 |
| 8 | CERTOLIZUMAB PEGOL | 308 |
| 9 | TOFACITINIB | 305 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 24 | 0.1091 |
| 1 | PSEUDOEPHEDRINE HCL | 222 | 0.0608 |
| 2 | CORTISONE ACETATE | 233 | 0.0503 |
| 3 | DESOXIMETASONE | 286 | 0.0432 |
| 4 | CAFFEINE CITRATE | 28 | 0.0401 |
| 5 | CETIRIZINE HCL, PSEUDOEPHEDRINE HCL | 13 | 0.0342 |
| 6 | CETIRIZINE HYDROCHLORIDE TABLETS | 230 | 0.0233 |
| 7 | PSEUDOEPHEDRINE HYDROCHLORIDE | 202 | 0.0221 |
| 8 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 9 | SARILUMAB | 133 | 0.0179 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 365 |
| 1 | Corticosteroid [EPC] | 337 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 331 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 312 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 309 |
| 5 | Vitamin D [EPC] | 274 |
| 6 | Vitamin B12 [EPC] | 273 |
| 7 | Vitamin C [EPC] | 273 |
| 8 | Antirheumatic Agent [EPC] | 269 |
| 9 | Aminosalicylate [EPC] | 244 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Receptor Antagonist [EPC] | 309 | 0.0043 |
| 1 | Antirheumatic Agent [EPC] | 269 | 0.0036 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 312 | 0.0036 |
| 3 | Aminosalicylate [EPC] | 244 | 0.0030 |
| 4 | Interleukin-12 Antagonist [EPC] | 156 | 0.0026 |
| 5 | Interleukin-23 Antagonist [EPC] | 156 | 0.0023 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 231 | 0.0016 |
| 7 | Vitamin D [EPC] | 274 | 0.0015 |
| 8 | Vitamin B12 [EPC] | 273 | 0.0014 |
| 9 | Vitamin C [EPC] | 273 | 0.0014 |